PENG Block for Traumatic Hip Fracture in the Emergency Department

Sponsor
Dalin Tzu Chi General Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04997785
Collaborator
Far Eastern Memorial Hospital (Other)
200
1
2
16.2
12.4

Study Details

Study Description

Brief Summary

The study is a multicenter single-blinded randomized comparative trial. Adult patients older than 20 years of age presenting with acute hip fracture in emergency department between January 1st, 2021 and December 31st, 2021 will be enrolled. Included patients will receive analgesia with either pericapsular nerve group (PENG) block or parenteral opioids. The primary outcome measure was pain scores (Numeric Rating Scale (NRS) 0 to 10). Secondary outcomes were rescue opioids use, complications, length of hospital stay, and patient-reported outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block
N/A

Detailed Description

Study design and setting This is multicenter, randomized controlled comparative trial conducted at Far Eastern Memorial Hospital and Dalin Tzu Chi Hospital, which are academic, level 1 trauma centers in Taiwan. The investigators plan to conduct the study from January 1st to May 8th, 2022. It will be paused temporarily if local coronavirus disease 2019 (COVID-19) virus pandemic restrictions. The trial is registering on ClinicalTrials.gov number. The study was reviewed and approved by the Institutional Review Board. The study conforms to the Consolidated Standards of Reporting Trials (CONSORT) and the CONSORT extension for trials reporting patient- related outcomes.

Selection of participants Patients aged >20 years presenting to the emergency department (ED) with a diagnosis of traumatic hip fracture from J January 1st to December 31th, 2021 will be included. Tthe investigators exclude patients who are aged <20 years, have coagulopathy, injection site infection, allergy to opioids or local anesthetics, initial pulse oximetry measures of oxygen saturation <92%, initial systolic blood pressure < 90 mmHg, chronic opioid use, non-communicative, experiences major trauma, fractures happened > 24 hours, and request conservative(non-operative) treatments. The investigators also exclude patients if the nerve block (NB) providers are unavailable. Written informed consent is acquired from all participants.

Randomization procedures and rationale All the included patients are randomized to either PENG block or intravenous morphine. Because PENG block is a novel technique for regional hip analgesia, well-trained emergency physicians are not available every day. Randomizing patients at the point of ED visit was considered impractical. Therefore, the investigators randomize each visit week before the study begins, and well-trained PENG block providers will be arranged on duty in the weeks randomized for PENG block. The unit of randomization will be the weeks, using random number generation in Microsoft Excel by a statistician who is not involved in the trial.

Study intervention PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (BD® 20G × 90 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators used 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention. Regimens of regional anesthesia with a longer duration of action are not preferred in our department because delayed onset of regional anesthesia particularly impedes orthopedic assessment in EDs. Dosage of intravenous morphine was determined according to 0.1 mg per kg; EPs were instructed to aim to reduce the pain by 50% or per patient request. They were encouraged to wait for at least 15 minutes after the study procedure before administering additional analgesia.

Outcome measures Primary outcome was postdose NRS pain score. NRS score was assessed as part of standard care at various timepoints, including at baseline, immediately after the analgesic treatment, at 10, 30, 60, and 120 minutes postdose time points, every 2 h thereafter until discharge from the ED, and at the time of discharge from the ED and arrival at the orthopedic ward before surgery.

Secondary outcomes were postdose quadriceps strength, rescue opiate use, complications, length of hospital stay, and patient-reported outcomes.

Quadriceps strength was assessed using the knee extension test and Oxford muscle strength scale. Rescue opioid consumption was measured in morphine milligram equivalents (MME) administered over all ED visits during the study timeframe.Any complications or side effects of nerve blocks, including local infection, intravascular injection of local anesthetics and immediate systemic toxicity, will be recorded. In opioid group, any side effects of opioids such as drowsiness, desaturation, nausea and vomiting, delirium, or respiratory distress, will be recorded. Patient-reported outcome defined as patient satisfaction (120 minutes after initial analgesics, patients were asked whether they would choose the same anesthetic handling; "yes" or "no").

Sample size calculation and statistical analyses Sample size could not be calculated, as there is no prior trial on comparison of PENG block and intravenous morphine in patient with hip fractures. This trial will be a pilot trial. Hence, the investigators intend to recruit 200 participants in total using a 1:1 allocation ratio, with 100 participants randomised into each arm. Chi-squared test or Fisher's exact test was used for categorical variables, and Student's t-test was used for continuous variable. Logistic regression was used to analyze data with dichotomous outcomes; p < 0.05 was considered statistically significant.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel AssignmentParallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Comparison of Ultrasound-guided Pericapsular Nerve Group (PENG) Block and Parenteral Opioids Alone in Patients With Traumatic Hip Fracture in the Emergency Department: A Multicenter Randomized Controlled Trial
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
May 8, 2022
Anticipated Study Completion Date :
May 8, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound-guided Pericapsular Nerve Group (PENG) Block

PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.

Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block
PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.

Active Comparator: Intravenous Morphine

Dosage of intravenous morphine was determined according to 0.1 mg per kg; EPs were instructed to aim to reduce the pain by 50% or per patient request.

Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block
PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.

Outcome Measures

Primary Outcome Measures

  1. Pain intensity difference (PID) [24 hours]

    Pain intensity was investigated using the 11-point numeric rating-scale (NRS) from 0 (no pain) to 10 (worst pain), and pain-intensity difference(PID) represents the difference in NRS scores between any observation time and the baseline.

Secondary Outcome Measures

  1. postdose quadriceps strength [24 hours]

    Quadriceps strength was assessed using the knee extension test by using Oxford muscle strength scale(from grade 0(no muscle movement) to grade 5(normal strength)) .

  2. Rescue opioid consumption [24 hours]

    measured in morphine milligram equivalents (MME)

  3. Incidence of nerve block complications [24 hours]

    Any complications or side effects of nerve blocks including local infection, intravascular injection of local anesthetics and immediate systemic toxicity.

  4. Incidence of opioid side effects [24 hours]

    Any side effects of opioids such as drowsiness, desaturation, nausea and vomiting, delirium, or respiratory distress.

  5. Patient-reported outcome [24 hours]

    patients were asked whether they would choose the same anesthetic handling; "yes" or "no"

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged >20 years presenting to the ED with a diagnosis of traumatic hip fracture during the study timeframe.
Exclusion Criteria:
  • are aged <20 years

  • coagulopathy

  • injection site infection

  • allergy to opioids or local anesthetics

  • initial pulse oximetry measures of oxygen saturation <92%

  • initial systolic blood pressure < 90 mmHg

  • chronic opioid use

  • non-communicative

  • major trauma

  • fractures happened > 24 hours

  • request conservative(non-operative) treatments.

  • The investigators also exclude patients if the NB providers are unavailable.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Chiayi Taiwan 622

Sponsors and Collaborators

  • Dalin Tzu Chi General Hospital
  • Far Eastern Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TSAI TOU YUAN, Emergency department physician, Principal Investigator, Dalin Tzu Chi General Hospital
ClinicalTrials.gov Identifier:
NCT04997785
Other Study ID Numbers:
  • A10904001
First Posted:
Aug 10, 2021
Last Update Posted:
Sep 14, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by TSAI TOU YUAN, Emergency department physician, Principal Investigator, Dalin Tzu Chi General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2021